Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023

BUY
$4.2 - $6.01 $1.64 Million - $2.35 Million
390,801 Added 92.37%
813,905 $3.42 Million
Q4 2022

Feb 14, 2023

SELL
$4.45 - $6.17 $982,951 - $1.36 Million
-220,888 Reduced 34.3%
423,104 $2.54 Million
Q3 2022

Nov 14, 2022

BUY
$5.36 - $7.43 $2.21 Million - $3.06 Million
411,568 Added 177.08%
643,992 $3.75 Million
Q2 2022

Aug 15, 2022

SELL
$3.55 - $6.27 $1.47 Million - $2.59 Million
-413,120 Reduced 64.0%
232,424 $1.39 Million
Q1 2022

May 16, 2022

SELL
$1.9 - $5.23 $96,675 - $266,112
-50,882 Reduced 7.31%
645,544 $3.02 Million
Q4 2021

Feb 14, 2022

BUY
$1.44 - $2.86 $517,871 - $1.03 Million
359,633 Added 106.78%
696,426 $1.73 Million
Q3 2021

Nov 15, 2021

BUY
$2.25 - $3.18 $165,719 - $234,216
73,653 Added 27.99%
336,793 $994,000
Q1 2021

May 17, 2021

BUY
$2.68 - $3.8 $594,801 - $843,375
221,941 Added 538.7%
263,140 $766,000
Q4 2020

Feb 16, 2021

BUY
$2.48 - $3.8 $71,592 - $109,698
28,868 Added 234.11%
41,199 $133,000
Q1 2019

May 15, 2019

SELL
$0.9 - $1.37 $99,497 - $151,457
-110,553 Reduced 89.97%
12,331 $12,000
Q1 2018

May 15, 2018

BUY
$2.7 - $4.06 $294,148 - $442,312
108,944 Added 781.52%
122,884 $479,000
Q4 2017

Feb 14, 2018

BUY
$2.47 - $3.34 $34,431 - $46,559
13,940
13,940 $37,000

About CTI BIOPHARMA CORP


  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.